As successful as the Alliance has been in using nanotechnology to address and solve many important questions in the laboratory, the ultimate measure of the programs success lies in the translation of research discoveries to the clinic. Currently, several nanotechnology-enabled diagnostic and therapeutic agents developed by Alliance investigators are in clinical trials, and many more are nearing that goal.